CFU-E
Colony-Forming Unit-Erythroid (CFU-E)[edit | edit source]
The Colony-Forming Unit-Erythroid (CFU-E) is a crucial stage in the hematopoietic process, specifically in the development of red blood cells. CFU-E is a progenitor cell that arises from the common myeloid progenitor and is committed to the erythroid lineage. This stage is characterized by its sensitivity to erythropoietin (EPO), a hormone that regulates red blood cell production.
Developmental Pathway[edit | edit source]
The development of CFU-E is part of the broader process of erythropoiesis, which is the production of red blood cells. The pathway begins with the hematopoietic stem cell (HSC), which differentiates into a common myeloid progenitor (CMP). From the CMP, the cell further differentiates into a burst-forming unit-erythroid (BFU-E), which eventually gives rise to the CFU-E.
CFU-E cells are highly responsive to erythropoietin, which stimulates their proliferation and differentiation into proerythroblasts. These proerythroblasts then undergo several stages of maturation, eventually becoming mature erythrocytes.
Role of Erythropoietin[edit | edit source]
Erythropoietin is a glycoprotein hormone produced primarily by the kidneys in response to low oxygen levels in the blood. It plays a critical role in the survival, proliferation, and differentiation of CFU-E cells. Erythropoietin binds to its receptor on the surface of CFU-E cells, activating signaling pathways that prevent apoptosis and promote cell division and maturation.
Clinical Significance[edit | edit source]
The regulation of CFU-E and erythropoiesis is vital for maintaining adequate levels of red blood cells and ensuring proper oxygen transport throughout the body. Disorders in this process can lead to conditions such as anemia, where there is a deficiency of red blood cells, or polycythemia, where there is an excess.
Therapeutically, recombinant erythropoietin is used to treat anemia, particularly in patients with chronic kidney disease or those undergoing chemotherapy, as these conditions can impair the body's natural erythropoietin production.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
